The remote patient monitoring market saw a big jump in the last year, with 7.1 million patients in 2016 enrolled in some form of digital health program featuring connected medical devices as a core part of their care plan, according to new data.
Swedish market research firm Berg Insight, which specializes in IoT verticals, tracked a 44 percent jump in remotely monitored patients last year. While...
Exco InTouch, a Nottingham, England-based clinical trial technology vendor responsible for powering early, influential mobile-enabled trials, has been acquired. ERT, a 45-year-old global clinical trial services company, purchased Exco last week for an undisclosed amount.
While both companies provide technology and services to support clinical trials, their focus areas are different, with ERT...
Apple has hired Dr. Mike Evans, a Toronto doctor who boasts 70,000 followers on his medical-themed YouTube channel. Evans was formerly a staff physician at St. Michael's Hospital in Toronto. As CBC reported, Evans is a mobile health enthusiast who has talked on his YouTube show about a future in which he might precribe an Apple Watch app for high blood pressure. Apple doesn't typically comment on...
Exco InTouch has launched a new app that creates a disease-specific social network for people with chronic urticaria, or hives. The app, called Target My Hives, was developed with funding and support from Novartis.
The app, available on Android and Apple devices, was just formally announced by the companies, but it currently has 2,000 patients registered from 61 countries. It launched in May....
Exco InTouch, the clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England, has raised $5 million (3.2 million pounds). The round was led by Albion Ventures, according to British news site HealthInvestor. Scottish Equity Partners, Exco's largest shareholder, also contributed to the round.
The Nottingham, England-based company...
A little over a year after completing a pilot study, pharmaceutical company AstraZeneca and Exco InTouch have launched a mobile-enabled program in the UK to help patients manage their chronic obstructive pulmonary disease (COPD), called Me&MyCOPD.
The program has three components -- a portal in which patients can connect with providers, a server on which information is saved and messages are...
At the mHealth Summit outside of Washington, D.C. last week, Mike Shilling, director of business development at Exco InTouch, shared three examples of mobile-enabled clinical trials that recently finished up or are still underway. The trials each leveraged mobiles in different ways and helped highlight a few of the strategies for deploying them in support of a trial as well as the various...
Clinical Ink, a pharma-focused mobile clinical trial data collection company, has raised $4.3 million. FCA Venture partners led the round, with additional funding from 10 undisclosed angel investors.
Clinical Ink makes SureSource, a windows-based tablet software for healthcare providers to collect clinical trial data electronically at the point of care. They use Windows tablets because stylus...
Over the span of two days last week, Voalte, Audax Health and Google made mobile health hires. Over the span of a month, there have been seven total hiring announcements. While Voalte's new hire has a background in health, some, like Audax's addition of Zynga Chief Operating Officer (COO) David Ko was brought on to grow the company in a new way. MobiHealthNews has compiled a list of all the...
A screenshot from Exco's clinical trial software.
One of our predictions at the start of the year was that 2013 would be a year for pharma to make big moves in mobile health. European pharmaceutical company AstraZeneca has begun that process, announcing a pilot, in partnership with Exco InTouch, to address chronic obstructive pulmonary disease (COPD) in the UK using mobile and online tools....
